Source: International Congress 2019 – Complex respiratory infections in clinical practice
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
S. Anapurapu (Milan, Italy), A. Bonagoni (Milan, Italy), W. Hooper (Princeton, United States of America), A. SAAID (Levallois-Perret, France), N. Durand (Levallois-Perret, France), C. Houee (Levallois-Perret, France), M. Alegre (Folkestone, United Kingdom). Clinical efficacy and safety evaluation of a novel seawater-based hypertonic solution in common cold patients. 4587

Member's Comments

No comment yet.

Related content which might interest you: Safety and efficacy of 7% hypertonic saline in patients with bronchiectasis Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Efficacy and effectiveness in long-term treatment with different ”new[dcdquote] drug's associations in cold patients Source: Eur Respir J 2003; 22: Suppl. 45, 52s Year: 2003 The safety, efficacy and utility of cold air challenge in UK schoolchildren Source: Annual Congress 2008 - Diagnostic paediatric lung function: technical and clinical aspects Year: 2008 Hyaluronic acid improves tolerability to 7% hypertonic saline solution in bronchiectasis patients Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Safety, dose finding and efficacy of ectoine inhalation solution in patients with mild asthma Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010 An initial investigation by electronic survey of current UK physiotherapy practice into the use and delivery of nebulised isotonic saline Source: Annual Congress 2012 - New insights in the physical assessment and therapy of respiratory patients Year: 2012 Efficacy of hypertonic saline solution in infant with acute bronchiolitis Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007 The efficacy and tolerability of inhaled hypertonic saline in children with cystic fibrosis Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 Clinical surveys with nebulised hypertonic saline (HS) in CF children Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 Clinical pharmacology study of a new tobramycin solution for nebulisation Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005 Effectiveness and safety of hypertonic saline inhalation combined with exercise training in patients with chronic obstructive pulmonary disease: a randomized trial Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions Year: 2009 Efficacy of nasal wash with saline solution 2% NaCl in children with high nasal resistance Source: Eur Respir J 2001; 18: Suppl. 33, 120s Year: 2001 Therapeutic and diagnostic use of highly concentrated sodium chloride solution inhalations in pulmonology Source: Eur Respir J 2006; 28: Suppl. 50, 62s Year: 2006 Effectiveness of nebulised hypertonic saline on the respiratory management of children and young people with neuromuscular disease Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019 A randomised controlled trial on the effect of inhaled hypertonic saline on quality of life in primary ciliary dyskinesia Source: Eur Respir J , 49 (2) 1601770; DOI: 10.1183/13993003.01770-2016 Year: 2017 Evaluation of treatment with fixed dose combinations in asthma patients in primary care in Sweden by using mannitol challenge test Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012 Evaluation of acceptability, efficacy and safety of a novel dry powder inhaler in patients with persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 70s Year: 2007 Evaluation of efficacy and safety of budesonide/formeterol combination therapy in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006 Long-term efficacy and safety of tobramycin 300mg/4mL nebuliser solution in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012 Effects of intrabronchial terlipressin versus cold normal saline solution application in endobronchial bleeding Source: Annual Congress 2007 - Therapeutic bronchoscopy Year: 2007